A mouse pancreatic organoid model to compare PD-L1 blocking antibodies

Immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape for cancer patients, but diabetes, a rare, severe immune-related endocrinopathy, is linked to ICI therapy. It is unclear whether glycosylation of ICIs may play a role in the development of this adverse event and how the physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangyuan, Ghosh, Susmita, Park, JuMe, Shin, Hyunsu, Garige, Mamatha, Reaman, Gregory, Sourbier, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639566/
https://www.ncbi.nlm.nih.gov/pubmed/36334035
http://dx.doi.org/10.1080/19420862.2022.2139886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639566/
https://www.ncbi.nlm.nih.gov/pubmed/36334035
http://dx.doi.org/10.1080/19420862.2022.2139886

Ejemplares similares